Tilray® Expands Global Leadership Team with New COO and CFO Former Revlon executive, Jon Levin, joins as Chief Operating Officer and former Molson Coors and Pharmaca executive, Michael Kruteck joins as Chief Financial Officer Current Tilray CFO, Mark Castaneda, to stay on in strategic business development role NANAIMO, British Columbia-January 14, 2020-(BUSINESS WIRE)–Tilray, Inc. (NASDAQ: […] READ MORE: https://www.newcannabisventures.com/tilray-adds-cpg-veterans-to-its-senior-leadership/
NANAIMO, British Columbia–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: TILRAY EXPORTS FIRST-EVER COMMERCIAL SHIPMENT OF MEDICAL CANNABIS ALLOWED INTO ISRAEL Company signs 2.5 tonne strategic partnership agreement with Canndoc to address growing demand for medical cannabis products in Israeli market Export to Israel originates from Tilray’s Portugal facility; Tilray…
NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced it has entered into a agreement with Canndoc Ltd., (“Canndoc”), a wholly-owned subsidiary of InterCure Ltd. (TASE: INCR), through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. (“Tilray Portugal”), to export a wholesale shipment of up to 2.5 tonnes of medical cannabis from…
High Park™ Reveals its New Portfolio of “Cannabis 2.0” Brands and Products New portfolio additions include edibles, confectionery goods, CBD-beverages and more, expanding High Park’s existing broad-based portfolio of brands and products TORONTO, December 17, 2019–(BUSINESS WIRE)–Today, High Park Holdings Ltd. (“High Park”), a wholly-owned subsidiary of Tilray, Inc. (NASDAQ:TLRY), proudly introduces its phase two […] READ MORE: https://www.newcannabisventures.com/tilray-unveils-next-gen-cannabis-products/
NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced that the merger with Privateer Holdings, Inc. (“Privateer”), closed on December 12, 2019. Mark Castaneda, Chief Financial Officer of Tilray, said: “We appreciate the long-term confidence that Privateer has in the Tilray business and we look forward to…
Tilray (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, on Wednesday announced its wholly-owned subsidiary Tilray Portugal, Unipessoal Lda. (“Tilray Portugal”) has received its Good Manufacturing Practice (“GMP”) certification in accordance with European Union standards, for its manufacturing facility in Cantanhede, Portugal. According to the update, Infarmed, the Portuguese National Authority of Medicines and Health Products,…
Cannabis stocks fell for a third straight session on Wednesday, as Tilray’s mixed third-quarter earnings failed to light a fire under the battered sector. READ MORE: https://finance.yahoo.com/m/1603de78-d346-3018-9ca9-a2a6e55baf20/cannabis-stocks-slide-for.html?.tsrc=rss
Tilray, Inc. Reports Third Quarter 2019 Financial Results Revenue Increased 409% to $51.1 (C$67.8) Million in the Third Quarter of 2019 Compared to the Prior Year Period International Medical Revenue Grew More Than Five-Fold Compared to the Prior Year Period NANAIMO, British Columbia, November 12, 2019–(BUSINESS WIRE)–Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a […] READ MORE: https://www.newcannabisventures.com/tilray-generates-51-1-million-revenue-in-q3/
NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, reports financial results for the third quarter ended September 30, 2019. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. “Our performance in the third quarter, including solid revenue growth and sequential gross…
NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, announced today it will report results for the third quarter ended September 30, 2019 on Tuesday, November 12, 2019 after market close. The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors interested in participating in the…
Scandals have engulfed the sector many times, especially for CannTrust, Curaleaf, and Hexo. Could Tilray be next on the cannabis scandal radar? READ MORE: https://finance.yahoo.com/m/7ac52991-af89-3e2a-ac76-7d6e8a97b1f2/cannabis-scandal-radar:-is.html?.tsrc=rss
After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150. READ MORE: https://finance.yahoo.com/m/d0a4e6d4-e606-3039-a0f6-9270fda589e3/tilray:-are-analysts.html?.tsrc=rss